Patrick Thomas Kennedy's most recent trade in Jazz Pharmaceuticals plc was a trade of 1,840 Ordinary Shares done at an average price of $241.4 . Disclosure was reported to the exchange on Aug. 31, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Jazz Pharma PLC | Patrick Thomas Kennedy | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 241.39 per share. | 31 Aug 2026 | 1,840 | 6,452 (0%) | 0% | 241.4 | 444,158 | Ordinary Shares |
| Jazz Pharma PLC | Patrick Thomas Kennedy | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.07 per share. | 31 Aug 2026 | 15 | 8,292 (0%) | 0% | 244.1 | 3,661 | Ordinary Shares |
| Jazz Pharma PLC | Patrick Thomas Kennedy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2026 | 1,605 | 8,307 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharma PLC | Patrick Thomas Kennedy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2025 | 3,507 | 8,661 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharma PLC | Patrick Thomas Kennedy | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 111.25 per share. | 07 Aug 2025 | 1,959 | 6,702 (0%) | 0% | 111.3 | 217,940 | Ordinary Shares |
| Jazz Pharma PLC | Patrick Thomas Kennedy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2024 | 3,731 | 5,154 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharma PLC | Patrick Thomas Kennedy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 1,423 | 1,423 (0%) | 0% | 0 | Common Stock |